Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?

Arch Dis Child Fetal Neonatal Ed. 2001 Mar;84(2):F96-F100. doi: 10.1136/fn.84.2.f96.

Abstract

Objective: To examine the number and volume of red blood cell transfusions (RBCTs) in very and extremely low birthweight infants under restrictive red blood cell transfusion guidelines without erythropoietin administration, and to compare the results with those reported in similar infants receiving erythropoietin.

Methods: From April 1996 to June 1999, all RBCTs given to infants with a birth weight of less than 1500 g were prospectively recorded. Data on RBCT combined with erythropoietin treatment and RBCT guidelines were extracted from four prospective randomised trials of erythropoietin for anaemia of prematurity.

Results: When the restrictive RBCT guidelines were followed, the number of RBCTs and volume transfused were similar to those reported during erythropoietin administration.

Conclusions: RBCT guidelines may have a similar impact on RBCT in very low birthweight infants to the administration of erythropoietin. The effect of RBCT guidelines on RBCT frequency should be considered when evaluating the efficacy of erythropoietin administration to preterm infants.

Publication types

  • Comparative Study
  • Meta-Analysis

MeSH terms

  • Erythrocyte Transfusion / methods*
  • Erythrocyte Transfusion / statistics & numerical data
  • Erythropoietin / therapeutic use*
  • Hematocrit
  • Humans
  • Infant, Newborn
  • Infant, Very Low Birth Weight*
  • Practice Guidelines as Topic*
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Treatment Outcome

Substances

  • Recombinant Proteins
  • Erythropoietin